The U.S. previously recommended more childhood vaccines than any peer nation, according to the HHS, which pointed out that ...

After shepherding the company through its first approval and the successful launch of blockbuster autoimmune drug Vyvgart, ...

Initiatives from former President Joe Biden and current President Donald Trump have been effective in reducing the prices of ...

A recent survey shows that healthcare professionals have varied feelings on the direct-to-patient (DTP) drug sale platforms ...

Daiichi Sankyo plans to splash out some 300 billion yen ($1.9 billion) on Enhertu manufacturing facilities across the globe, ...

Bausch + Lomb has partnered with the glaucoma community once again, launching its fifth annual fundraising challenge and ...

Shortly after scoring a historic FDA nod for its Wegovy pill, Novo Nordisk is off to the races with the oral obesity med’s ...

A positive top-line readout from a phase 3 trial has emboldened Incyte to seek the FDA’s blessing for the company’s Monjuvi ...

Welcome to Fierce Pharma's regulatory tracker for the first half of 2026. | In this tracker, Fierce Pharma is recording the ...

Foresee Pharmaceuticals has shown that a long-acting version of its injectable prostate cancer med Camcevi can help patients ...

Vanda also sells sleep disorder drug Hetlioz, which reached the market in 2014, and relapsing multiple sclerosis treatment ...

In turn, the company—which is broadly seeking to develop inflammatory drugs targeting the complement system—anticipates ...